Chemistry: molecular biology and microbiology – Enzyme – proenzyme; compositions thereof; process for...
Patent
1986-08-08
1989-12-05
Weimar, Elizabeth C.
Chemistry: molecular biology and microbiology
Enzyme , proenzyme; compositions thereof; process for...
4351723, 4352522, 4352523, 43525233, 43525235, 435254, 435320, 536 27, 935 14, 935 27, 935 34, 935 60, 935 68, 935 72, C12N 900, C12N 1500, C12P 102, C12P 104
Patent
active
048852511
ABSTRACT:
The present invention comprises novel DNA compounds that encode isopenicillin N synthetase and also comprises related methods, transformants, and polypeptides. The novel isopenicillin N synthetase-encoding DNA, together with its associated transcriptional and translational activating sequence, was isolated from Cephalosporium acremonium and cloned into an E. coli cloning vector. The isopenicillin N synthetase-encoding DNA has been used to construct novel E. coli expression vectors that drive expression of a stable, active, and novel isopenicillin N synthetase in E. coli. The intact C. acremonium isopenicillin N synthetase-encoding DNA and associated transcriptional and translational activating sequence have also been used to construct C. acremonium expression vectors that drive expression of the isopenicillin N synthetase in C. acremonium. The C. acremonium transcriptional and translational activating sequence has further been fused to a hygromycin phosphotransferase-encoding DNA segment and placed onto C. acremonium expression vectors. Useful derivatives of the novel compounds and vectors are also described.
REFERENCES:
patent: 4178210 (1979-12-01), Demain et al.
patent: 4307192 (1981-12-01), Demain et al.
patent: 4588585 (1986-05-01), Mark et al.
patent: 4618578 (1986-10-01), Burke et al.
Kaster et al., 1983 NAR, 11:6895.
Van Solingen et al., 1985, J. Cell. Biochem., Suppl. 9C:(Abstr. 1576), 174.
Penalva et al., 1985, J. Cell. Biochem., Suppl. 9C:(Abstr. 1570), 172.
Dalbodie-McFarland et al., 1982, PNAS, 79:6409-6413.
Suggs et al., 1981, PNAS, 78:6613.
Pang et al., 1984, Biochem. J., 222:789.
Skatrud et al., 1984, Current Genetics, 8:155.
S. W. Queener and Norbert Neuss, The Chemistry and Biology of .beta.-Lactam Antibiotics, vol. 3, Chapter 1, (1982, Academic Press, Inc.).
Wolfe et al., 1984, Science, 226:1386.
Jeffrey T. Fayerman, Abstract of an Oral Presentation entitled "Protein Engineering" at the 4th Stony Brook Symposium on Molecular Biology, May 20-22, 1985.
Skatrud et al., Abstract of an Oral Presentation entitled, "The Application of Recombinant DNA Technology to the Antibiotic Producing Filamentous Fungus Cephalosporium acremonium" at the 4th Annual Toyobo Biotechnology Foundation Symposium, Tokyo, Japan, Aug. 30-31, 1985.
Thomas D. Ingolia, a Poster Session at a Meeting of the International Union of Pure & Applied Chemistry, Manchester, England, Sep. 8-13, 1985.
Jerry L. Chapman, Abstract of an Oral Presentation at the 1985 Annual Meeting of the Society for Industrial Microbiology, Boston, Mass., Aug. 3-9, 1985.
Samson et al., 1985, Nature, 318:191-194.
Juarin and Grundstrom, 1981, Proc. Natl. Acad. Sci., 78(8):4897-4901.
Godfrey Otis W.
Ingolia Thomas D.
Queener Stephen W.
Samson Suellen M.
Skatrud Paul L.
Eli Lilly and Company
Levy Ron K.
Peet Richard C.
Weimar Elizabeth C.
Whitaker Leroy
LandOfFree
Recombinant DNA expression vectors and DNA compounds which encod does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant DNA expression vectors and DNA compounds which encod, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant DNA expression vectors and DNA compounds which encod will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2034141